Cargando…

A novel mode of action for COX‐2 inhibition: Targeting ATPase domain of HSP90 induces ubiquitin degradation of new client protein COX‐2

Detalles Bibliográficos
Autores principales:	Zhang, Man, Cui, Jing, Shen, Fukui, Ye, Lili, Cheng, Chuanjing, Li, Yang, Zhang, Qiuyang, Niu, Lin, Hou, Yuanyuan, Bai, Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787097/ https://www.ncbi.nlm.nih.gov/pubmed/35075789 http://dx.doi.org/10.1002/ctm2.705

Ejemplares similares

HECTD3 Mediates an HSP90-Dependent Degradation Pathway for Protein Kinase Clients
por: Li, Zhaobo, et al.
Publicado: (2017)

Cyclodepsipeptide toxin promotes the degradation of Hsp90 client proteins through chaperone-mediated autophagy
por: Shen, Shensi, et al.
Publicado: (2009)

Cox-2: where are we in 2003? - Cardiovascular risk and Cox-2 inhibitors
por: Mukherjee, Debabrata, et al.
Publicado: (2003)

Select Dietary Phytochemicals Function as Inhibitors of COX-1 but Not COX-2
por: Li, Haitao, et al.
Publicado: (2013)

C0818, a novel curcumin derivative, interacts with Hsp90 and inhibits Hsp90 ATPase activity
por: Fan, Yingjuan, et al.
Publicado: (2017)

SUV39H1 is a New Client Protein of Hsp90 Degradated by Chaetocin as a Novel C-Terminal Inhibitor of Hsp90
por: Lian, Bin, et al.
Publicado: (2021)

Targeting the Hsp90-Cdc37-client protein interaction to disrupt Hsp90 chaperone machinery
por: Li, Ting, et al.
Publicado: (2018)

The Mechanism of Hsp90 ATPase Stimulation by Aha1
por: Wolmarans, Annemarie, et al.
Publicado: (2016)

Review: The HSP90 molecular chaperone—an enigmatic ATPase
por: Pearl, Laurence H.
Publicado: (2016)

The APE2 Exonuclease Is a Client of the Hsp70–Hsp90 Axis in Yeast and Mammalian Cells
por: Omkar, Siddhi, et al.
Publicado: (2022)

The mitochondrial TMEM177 associates with COX20 during COX2 biogenesis
por: Lorenzi, Isotta, et al.
Publicado: (2018)

Expression and correlation of COX-2 and NUCB1 in colorectal adenocarcinoma
por: Zhang, Yuanyuan, et al.
Publicado: (2023)

Quercetin sensitizes glioblastoma to t-AUCB by dual inhibition of Hsp27 and COX-2 in vitro and in vivo
por: Li, Junyang, et al.
Publicado: (2016)

Viscum album-Mediated COX-2 Inhibition Implicates Destabilization of COX-2 mRNA
por: Saha, Chaitrali, et al.
Publicado: (2015)

Exploring the role of COX-2 in Alzheimer's disease: Potential therapeutic implications of COX-2 inhibitors
por: Moussa, Nathalie, et al.
Publicado: (2023)

Pathogenesis of colorectal carcinoma and therapeutic implications: the roles of the ubiquitin–proteasome system and Cox-2
por: Voutsadakis, Ioannis A
Publicado: (2007)

Sulphoxythiocarbamates modify cysteine residues in HSP90 causing degradation of client proteins and inhibition of cancer cell proliferation
por: Zhang, Y, et al.
Publicado: (2014)

Pharmacologic Inhibition of COX-1 and COX-2 in Influenza A Viral Infection in Mice
por: Carey, Michelle A., et al.
Publicado: (2010)

Differential usage of COX-1 and COX-2 in prostaglandin production by mast cells and basophils
por: Bando, Tomoyuki, et al.
Publicado: (2017)

Participation of COX-1 and COX-2 in the contractile effect of phenylephrine in prepubescent and old rats
por: Guevara-Balcazar, Gustavo, et al.
Publicado: (2017)

Hsp110 Chaperones Control Client Fate Determination in the Hsp70–Hsp90 Chaperone System
por: Mandal, Atin K., et al.
Publicado: (2010)

Ge-Gen Decoction Exerts an Anti-Primary Dysmenorrhea Effect in Rats by Inactivating the HSP90/NLRP3/NF-κB/COX-2 Pathway
por: Xie, Yazhen, et al.
Publicado: (2023)

Tamoxifen Enhances the Hsp90 Molecular Chaperone ATPase Activity
por: Zhao, Rongmin, et al.
Publicado: (2010)

Interleukin-17 Indirectly Promotes M2 Macrophage Differentiation through Stimulation of COX-2/PGE2 Pathway in the Cancer Cells
por: Li, Qingli, et al.
Publicado: (2014)

COX-1, and not COX-2 activity, regulates airway function: relevance to aspirin-sensitive asthma
por: Harrington, Louise S., et al.
Publicado: (2008)

COX16 promotes COX2 metallation and assembly during respiratory complex IV biogenesis
por: Aich, Abhishek, et al.
Publicado: (2018)

Aspirin for the prevention and treatment of pre‐eclampsia: A matter of COX‐1 and/or COX‐2 inhibition?
por: Mirabito Colafella, Katrina M., et al.
Publicado: (2019)

COX-2 Inhibitors and Gastric Cancer
por: Wang, Zhen, et al.
Publicado: (2014)

Adverse Effects of COX-2 Inhibitors
por: Sharma, Jagdish N., et al.
Publicado: (2005)

COX-2 Overexpression in Schneiderian Papillomas
por: Suh, Jeffrey D., et al.
Publicado: (2020)

The roles of COX-2 in protozoan infection
por: Wang, Xinlei, et al.
Publicado: (2023)

Radiolabeled COX-2 Inhibitors for Non-Invasive Visualization of COX-2 Expression and Activity — A Critical Update
por: Laube, Markus, et al.
Publicado: (2013)

Pancreatic Stellate Cells (PSCs) express Cyclooxygenase-2 (COX-2) and pancreatic cancer stimulates COX-2 in PSCs
por: Yoshida, Seiya, et al.
Publicado: (2005)

Hsp90 (Heat Shock Protein 90) Inhibitor Occupancy Is a Direct Determinant of Client Protein Degradation and Tumor Growth Arrest in Vivo
por: Tillotson, Bonnie, et al.
Publicado: (2010)

Natural Iminosugar (+)-Lentiginosine Inhibits ATPase and Chaperone Activity of Hsp90
por: Dal Piaz, Fabrizio, et al.
Publicado: (2012)

Cooperation of local motions in the Hsp90 molecular chaperone ATPase mechanism
por: Schulze, Andrea, et al.
Publicado: (2016)

Structural Basis of Parasitic HSP90 ATPase Inhibition by Small Molecules
por: Tassone, Giusy, et al.
Publicado: (2022)

Selective COX-2 inhibition affects fatty acids, but not COX mRNA expression in patients with FAP
por: Almendingen, Kari, et al.
Publicado: (2010)

Interaction between COX-1 and COX-2 increases susceptibility to ischemic stroke in a Chinese population
por: Zhao, Lei, et al.
Publicado: (2019)

Upregulation of COX4-2 via HIF-1α in Mitochondrial COX4-1 Deficiency
por: Douiev, Liza, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ol3o2ank0sl1ebclte1mj95nod